Nothing Special   »   [go: up one dir, main page]

ATE287878T1 - Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten - Google Patents

Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten

Info

Publication number
ATE287878T1
ATE287878T1 AT97942872T AT97942872T ATE287878T1 AT E287878 T1 ATE287878 T1 AT E287878T1 AT 97942872 T AT97942872 T AT 97942872T AT 97942872 T AT97942872 T AT 97942872T AT E287878 T1 ATE287878 T1 AT E287878T1
Authority
AT
Austria
Prior art keywords
oxazepine
dopamine
preparation
receptor antagonists
thiazepine derivatives
Prior art date
Application number
AT97942872T
Other languages
English (en)
Inventor
Oskar Axelsson
Dan Peters
Jorgen Scheel-Krueger
Nielsen Elsebet Stergaard
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of ATE287878T1 publication Critical patent/ATE287878T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/02—Seven-membered rings
    • C07D267/08—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D267/10—Seven-membered rings having the hetero atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
AT97942872T 1996-08-23 1997-08-22 Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten ATE287878T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK88396 1996-08-23
PCT/EP1997/004587 WO1998007710A1 (en) 1996-08-23 1997-08-22 Disubstituted morpholine, oxazepine or thiazepine derivatives, their preparation and their use as dopamine d4 receptor antagonists

Publications (1)

Publication Number Publication Date
ATE287878T1 true ATE287878T1 (de) 2005-02-15

Family

ID=8098601

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97942872T ATE287878T1 (de) 1996-08-23 1997-08-22 Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten

Country Status (6)

Country Link
US (2) US6207662B1 (de)
EP (1) EP0920423B1 (de)
AT (1) ATE287878T1 (de)
AU (1) AU4455397A (de)
DE (1) DE69732359T2 (de)
WO (1) WO1998007710A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043670A1 (en) * 1998-02-26 1999-09-02 Neurogen Corporation Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
US6084098A (en) 1999-02-26 2000-07-04 Neurogen Corporation Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
US6284759B1 (en) 1998-09-30 2001-09-04 Neurogen Corporation 2-piperazinoalkylaminobenzo-azole derivatives: dopamine receptor subtype specific ligands
GB201108825D0 (en) 2011-05-25 2011-07-06 Univ Dundee Morpholino compounds, uses and methods
WO2016065576A1 (en) * 2014-10-30 2016-05-06 Tianjin Weijie Pharmaceutical Co., Ltd. Process for preparation of high purity guaiacol glycidyl ether

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1260886A (en) 1969-06-20 1972-01-19 Ici Ltd Process for aryloxymethylmorpholine derivatives
GB1310236A (en) 1970-05-21 1973-03-14 Ici Ltd Morpholine derivatives
GB1382526A (en) 1972-08-11 1975-02-05 Ici Ltd Morpholine derivatives
JPS4982677A (de) * 1972-12-18 1974-08-08
GB1412546A (en) 1973-08-08 1975-11-05 Ici Ltd Morpholine derivatives
GB1427097A (en) 1973-10-18 1976-03-03 Ici Ltd Optically-active morpholine derivatives
GB1436395A (en) 1973-12-13 1976-05-19 Ici Ltd Morpholine derivatives
GB1452701A (en) 1974-05-07 1976-10-13 Ici Ltd Morpholine derivatives
DE2728898A1 (de) 1977-06-27 1979-01-18 Thomae Gmbh Dr K Neue morpholinderivate
JPH01117860A (ja) 1987-10-30 1989-05-10 Dainippon Pharmaceut Co Ltd 安息香酸アミド誘導体
JPH02104572A (ja) 1988-10-13 1990-04-17 Dainippon Pharmaceut Co Ltd 安息香酸アミド誘導体
WO1993015052A1 (en) * 1992-01-28 1993-08-05 Smithkline Beecham Plc Compounds as calcium channel antagonists
GB9324018D0 (en) 1993-11-23 1994-01-12 Merck Sharp & Dohme Therapeutic agents
GB9411045D0 (en) 1994-06-02 1994-07-20 Smithkline Beecham Plc Compounds and use

Also Published As

Publication number Publication date
DE69732359T2 (de) 2005-06-23
DE69732359D1 (de) 2005-03-03
US6479491B1 (en) 2002-11-12
WO1998007710A1 (en) 1998-02-26
AU4455397A (en) 1998-03-06
US6207662B1 (en) 2001-03-27
EP0920423B1 (de) 2005-01-26
EP0920423A1 (de) 1999-06-09

Similar Documents

Publication Publication Date Title
ATE226189T1 (de) Saure gruppen enthaltende phenylderivate, ihre herstellung und ihre verwendung als chloridkanalblocker
WO1999042465A3 (en) Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
EA200401172A1 (ru) Производные n-[фенил(пиперидин-2-ил)метил]бензамида, способ их получения и их применение в терапии
EE9700283A (et) Bensimidasooli ühendid, nimetatud ühendeid sisaldavad farmatseutilised kompositsioonid ja nende kasutamine
ES530902A0 (es) Procedimiento para preparar derivados de piperazina
NZ511584A (en) Benzoxazole substituted piperazine and piperidine derivatives useful for treating central nervous disorders, depression and anxiety
JO2321B1 (en) 4-phenyl-pyridine derivatives
DE69401716D1 (de) Imidazo [1,2-a] pyrasin-4-on-derivate welche als ampa und nmda receptor antagonisten dienen
NZ528997A (en) Sulfonamides
PE20050587A1 (es) Derivados de diazindol-dicarbonilo-piperazinilo como agentes antivirales
ATE45734T1 (de) N-substituierte 2-aminothiazole, verfahren zu ihrer herstellung und ihre therapeutische anwendung.
NO964698L (no) Bicykliske aminderivater som inhibitorer av nitrogenoksid-syntetase
DK26289A (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
PE20030539A1 (es) Derivados de piperazina antagonistas de los receptores de somatostatina sst1
DE3762860D1 (de) 2-thiazolylimidazo(1,2-a)pyrimidine und ihre salze, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
ATE287878T1 (de) Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten
YU84901A (sh) Derivati 4-fenil-pirimidina
MXPA05012368A (es) Derivados de amidas del acido 2,3,4,5-tetrahidrobenzo[f] [1,4]oxazepina-5-carboxilico como inhibidores de gamma-secretasa para el tratamiento de la enfermedad de alzheimer.
CA2366205A1 (en) Biphenyl derivatives
ATE184593T1 (de) Aminosäurederivate und ihre verwendung als phospholipase-a2-inhibitoren
HUP0203695A2 (hu) Szubsztituált pirrol Mannichbázisok, előállításuk, alkalmazásuk és ilyent tartalmazó gyógyászati készítmény
BR0212932A (pt) Derivados de alquilaminopiridazinona substituìdos, processo para a preparação destes, composição farmacêutica contendo os mesmos e seus usos
DE3769333D1 (de) Acylaminomethylimidazo(1,2-a)pyrimidinderivate, ihre herstellung und therapeutische verwendung.
DE69110219D1 (de) 3-(1H-Indazol-3-yl)-4-pyridiname, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
DE3884319D1 (de) Imidazobenzodiazepine und ihre Säureadditionssalze, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und diese enthaltende Zubereitungen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties